Test early for verotoxin producing Escherichia coli

doi:10.1136/bmj.39583.767766.3A

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Roland L Salmon, consultant epidemiologist,
Meirion R Evans,
Brendan W Mason,
Dirk Werber

¹National Public Health Service for Wales, Temple of Peace and Health, Cardiff CF10 3NW
²Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany

roland.salmon{at}nphs.wales.nhs.uk

Murphy’s article on the management of bloody diarrhoea in children in primary care (and indeed his interests, judging from his reference 1) seems to be orientated towards the early diagnosis and treatment of inflammatory bowel disease.1 Some of his recommendations, however, particularly figure 1, should therefore be expanded so as not to be problematic for the management of infection, in general, and verotoxin producing …